Gene · 53345
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD. | JHEP Rep | 2025 | 41143242 | PubTator, text mining | PubMed |
| Steatotic liver disease and cancer: from pathogenesis to therapeutic targets. | eGastroenterology | 2025 | 41098801 | PubTator, text mining | PubMed |
| Clinical Predictors of Progression From Metabolic Dysfunction-Associated Steatotic Liver Disease to Cirrhosis: A Narrative Review. | Cureus | 2025 | 41054643 | PubTator, text mining | PubMed |
| Genomic medicine in hepatology: mechanisms and liver treatment strategies. | Mol Med | 2025 | 41023586 | PubTator, text mining | PubMed |
| Hot and Cold HCC: Uncoupling Viral Oncogenesis and Therapy. | Viruses | 2025 | 41012682 | PubTator, text mining | PubMed |
| Metabolic Signatures in Lean MASLD: Current Insights and Future Directions. | Metabolites | 2025 | 41002967 | PubTator, text mining | PubMed |
| Metabolic and genetic mechanisms of metabolic dysfunction-associated steatotic liver disease: an integrative perspective from molecular pathways to clinical challenges. | Front Endocrinol (Lausanne) | 2025 | 41001677 | PubTator, text mining | PubMed |
| Genetic risk score correlates with immune profile and risk of HCC and cirrhosis development in Hispanics with MASLD. | JHEP Rep | 2025 | 40995436 | PubTator, text mining | PubMed |
| PNPLA3 polymorphism worsens chemotherapy associated liver injury and affects overall survival in colorectal cancer patients with liver metastasis undergoing hepatic resection. | EBioMedicine | 2025 | 40961507 | PubTator, text mining | PubMed |
| Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers. | Int J Mol Sci | 2025 | 40943344 | PubTator, text mining | PubMed |
| Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients. | Clin Exp Hepatol | 2025 | 40904655 | PubTator, text mining | PubMed |
| [Analysis of gene expression in synovial fluid and blood of patients with knee osteoarthritis of Yang deficiency and blood stasis type]. | Zhongguo Gu Shang | 2025 | 40898937 | PubTator, text mining | PubMed |
| Call a spade a spade. | Hepatobiliary Surg Nutr | 2025 | 40893747 | PubTator, text mining | PubMed |
| Genetic Variants, Metabolic Dysfunction-Associated Fatty Liver Disease, and Major Health Outcomes in Older Adults. | Biomedicines | 2025 | 40868230 | PubTator, text mining | PubMed |
| Early lipid genetics: identification of common and rare genetic variants for lipid traits in Indian adolescents. | J Hum Genet | 2025 | 40841581 | PubTator, text mining | PubMed |
| Human-induced pluripotent stem cell-based hepatic modeling of lipid metabolism-associated TM6SF2-E167K variant. | Hepatology | 2025 | 40833996 | PubTator, text mining | PubMed |
| Genetic insights into alcohol-associated liver disease: integrative transcriptome-wide analysis identifies novel susceptibility genes. | Front Med (Lausanne) | 2025 | 40823550 | PubTator, text mining | PubMed |
| Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development. | JHEP Rep | 2025 | 40823170 | PubTator, text mining | PubMed |
| Contribution of PNPLA3, GCKR, MBOAT7, NCAN, and TM6SF2 Genetic Variants to Hepatocellular Carcinoma Development in Mexican Patients. | Int J Mol Sci | 2025 | 40806538 | PubTator, text mining | PubMed |
| Identification of biomarkers between coronary artery disease and non-alcoholic steatohepatitis: a combination of bioinformatics and machine learning. | Front Genet | 2025 | 40747105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53345/papers?page=6